p53 Immunostaining and Lung Cancer Survival
Author Information
Author(s): R. McLaren, I. Kuzu, M. Dunnill, A. Harris, D. Lane, K.C. Gatter
Primary Institution: Nuffield Department of Pathology, John Radcliffe Hospital
Hypothesis
Does p53 positivity in lung tumors correlate with patient survival?
Conclusion
The study found no significant correlation between p53 expression and patient survival in lung cancer.
Supporting Evidence
- 54% of the lung tumors showed positive staining for p53.
- No differences in survival were observed between p53 positive and negative cases.
- Previous studies indicated a similar percentage of p53 positivity in lung tumors.
Takeaway
The study looked at lung cancer tumors to see if a protein called p53 could help predict how long patients would live, but it found that it doesn't really help.
Methodology
Immunostaining of 125 lung tumors with a panel of anti-p53 antibodies and analysis of survival data.
Limitations
The study may not account for tumors that do not express p53 due to mutations or deletions.
Participant Demographics
Patients undergoing radical pulmonary resection for lung carcinoma, collected between 1984 and 1988.
Statistical Information
P-Value
p > 0.5
Want to read the original?
Access the complete publication on the publisher's website